# MRPL16

## Overview
MRPL16 is a gene that encodes the mitochondrial ribosomal protein L16, a critical component of the large subunit of the mitochondrial ribosome. This protein is integral to the process of mitochondrial protein synthesis, facilitating the translation of mitochondrial mRNA into proteins essential for mitochondrial function and energy production (O’Brien2003Properties). As a part of the mitoribosome, MRPL16 is synthesized in the cytoplasm and imported into the mitochondria, where it plays a non-redundant role in the assembly and function of the ribosomal complex (Cheong2020Expression). The protein's involvement in mitochondrial translation underscores its importance in cellular energy metabolism and viability. Alterations in MRPL16 expression have been linked to various cancers, highlighting its potential as a biomarker and therapeutic target (Lin2022Expression; Kim2017Mitochondrial).

## Function
MRPL16 encodes the mitochondrial ribosomal protein L16, which is a component of the large subunit of the mitochondrial ribosome. This protein plays a crucial role in mitochondrial protein synthesis by participating in the assembly and function of the ribosome, facilitating the translation of mitochondrial mRNA into functional proteins (O’Brien2003Properties). MRPL16 is active within the mitochondria, contributing to cellular energy production and overall mitochondrial function. The mitochondrial ribosome, composed of a small 28S subunit and a large 39S subunit, is essential for protein synthesis within mitochondria, and MRPL16 is a part of this complex structure (Zhang2003Identification).

The mitochondrial ribosomal proteins, including MRPL16, are encoded by nuclear genes, synthesized by cytoplasmic ribosomes, and imported into mitochondria, where they play a non-redundant role in the mitoribosome complex (Cheong2020Expression). The unique and essential roles of these proteins are underscored by their involvement in mitochondrial translation, which is vital for energy production and cellular viability (Cheong2020Expression). Dysfunctional mitochondrial translation often results in developmental arrest due to insufficient ATP production, highlighting the importance of MRPL16 in maintaining mitochondrial function and energy metabolism.

## Clinical Significance
MRPL16 has been implicated in various cancers due to its altered expression levels. In colorectal cancer, MRPL16 is notably upregulated in synchronous adenoma, suggesting its involvement in location-specific pathways such as oxidative phosphorylation (OXPHOS). This upregulation may enhance the accuracy of tumor class prediction, indicating its potential role in tumor progression and as a prognostic marker (Kim2017Mitochondrial).

In breast cancer, MRPL16 expression levels are associated with patient prognosis. Specifically, low levels of MRPL16 have been linked to poor prognosis in breast cancer patients. This suggests that MRPL16 could serve as a biomarker for identifying high-risk patients and may have therapeutic implications (Lin2022Expression).

The role of MRPL16 in cancer highlights its potential as a target for therapeutic strategies. Its involvement in mitochondrial processes, such as oxidative phosphorylation, suggests that alterations in MRPL16 expression could impact mitochondrial function and contribute to cancerous metabolic alterations. These findings underscore the importance of further research into MRPL16's role in cancer biology and its potential as a therapeutic target (Lin2022Expression; Kim2017Mitochondrial).

## Interactions



## References


[1. (O’Brien2003Properties) Thomas W. O’Brien. Properties of human mitochondrial ribosomes. IUBMB Life, 55(9):505–513, September 2003. URL: http://dx.doi.org/10.1080/15216540310001626610, doi:10.1080/15216540310001626610. This article has 111 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15216540310001626610)

[2. (Cheong2020Expression) Agnes Cheong, Ranjana Lingutla, and Jesse Mager. Expression analysis of mammalian mitochondrial ribosomal protein genes. Gene Expression Patterns, 38:119147, December 2020. URL: http://dx.doi.org/10.1016/j.gep.2020.119147, doi:10.1016/j.gep.2020.119147. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gep.2020.119147)

[3. (Kim2017Mitochondrial) Hyun-Jung Kim, Priyanka Maiti, and Antoni Barrientos. Mitochondrial ribosomes in cancer. Seminars in Cancer Biology, 47:67–81, December 2017. URL: http://dx.doi.org/10.1016/j.semcancer.2017.04.004, doi:10.1016/j.semcancer.2017.04.004. This article has 133 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.semcancer.2017.04.004)

[4. (Lin2022Expression) Xiaoyi Lin, Lijuan Guo, Xin Lin, Yulei Wang, and Guochun Zhang. Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer. Scientific Reports, June 2022. URL: http://dx.doi.org/10.1038/s41598-022-14724-7, doi:10.1038/s41598-022-14724-7. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-14724-7)

[5. (Zhang2003Identification) Zhaolei Zhang and Mark Gerstein. Identification and characterization of over 100 mitochondrial ribosomal protein pseudogenes in the human genome☆. Genomics, 81(5):468–480, May 2003. URL: http://dx.doi.org/10.1016/s0888-7543(03)00004-1, doi:10.1016/s0888-7543(03)00004-1. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0888-7543(03)00004-1)